Alambic Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,715	Closed	-$509K	–	469
2017 Q3	$509K	Buy	4,715 +1,240	+36%	+$134K	0.06%	345
2017 Q2	$351K	Sell	3,475 -330	-9%	-$33.3K	0.04%	433
2017 Q1	$342K	Buy	3,805 +445	+13%	+$40K	0.04%	479
2016 Q4	$256K	Buy	+3,360	New	+$256K	0.05%	453